23,648
Total Claims
$3.6M
Drug Cost
2,057
Beneficiaries
$1,748
Cost/Patient
Peer Comparison vs. 17,757 Ophthalmology providers
+191%
Cost per patient vs peers
$1,748 vs $600 avg
+45%
Brand preference vs peers
53.3% vs 36.7% avg
Brand vs Generic
47% generic
Brand: 12,609 claims · $3.2M
Generic: 11,039 claims · $398K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Bimatoprost | 2,777 | $867K |
| Netarsudil Mesylate | 1,675 | $616K |
| Brimonidine Tartrate/Timolol | 1,353 | $478K |
| Netarsudil Mesylat/Latanoprost | 710 | $270K |
| Brimonidine Tartrate | 712 | $229K |
| Cyclosporine | 165 | $139K |
| Bimatoprost | 33 | $108K |
| Brimonidine Tartrate/Timolol | 595 | $82K |
| Nepafenac | 195 | $74K |
| Prednisolone Acetate | 1,378 | $70K |
| Methazolamide | 264 | $68K |
| Dorzolamide Hcl/Timolol Maleat | 2,867 | $63K |
| Latanoprost | 4,268 | $50K |
| Travoprost | 353 | $48K |
| Loteprednol Etabonate | 123 | $34K |
Prescribing Profile
32
Unique Drugs
Patient Profile
79
Avg Age
54%
Female
2.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data